[1]刘建,王淑霞,张晓童,等.小儿结核性脑膜炎外周血补体因子 H、载脂蛋白A1和淀粉样蛋白A表达水平变化及其临床意义[J].卒中与神经疾病杂志,2022,29(05):422-426.[doi:10.3969/j.issn.1007-0478.2022.05.005]
　Liu Jian*,Wang Shuxia,Zhang Xiaotong,et al.The expression levels of peripheral blood complement factor H, apolipoprotein A1 and amyloid A in children with tuberculous meningitis and their clinical significance[J].Stroke and Nervous Diseases,2022,29(05):422-426.[doi:10.3969/j.issn.1007-0478.2022.05.005]
点击复制

小儿结核性脑膜炎外周血补体因子 H、载脂蛋白A1和淀粉样蛋白A表达水平变化及其临床意义()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第29卷
期数:
2022年05期
页码:
422-426
栏目:
论著
出版日期:
2022-10-10

文章信息/Info

Title:
The expression levels of peripheral blood complement factor H, apolipoprotein A1 and amyloid A in children with tuberculous meningitis and their clinical significance
文章编号:
1007-0478(2022)05-0422-05
作者:
刘建; 王淑霞; 张晓童; 陈鹏
024000 内蒙古赤峰学院附属医院儿科（刘建）；赤峰市宁城县中心医院普儿科（王淑霞）；赤峰市宁城县中心医院-感染性疾病科（张晓童）；满洲里市人民医院儿科（陈鹏）
Author(s):
Liu Jian*;  Wang Shuxia;  Zhang Xiaotong;  et al.
Department of Pediatrics, Affiliated Hospital of Inner Mongolia Chifeng University, Chifeng 024000
关键词:
结核性脑膜炎; 补体因子; H; 淀粉样蛋白A; 载脂蛋白A1
Keywords:
Tuberculous; meningitis Complement factor H; Amyloid A; Apolipoprotein A1
分类号:
R529.3
DOI:
10.3969/j.issn.1007-0478.2022.05.005
文献标志码:
A
摘要:
目的 探讨小儿结核性脑膜炎（Tuberculous meningitis，TBM）外周血补体因子 H（Complement factor H，CFH）、载脂蛋白A1（Apolipoprotein AI，ApoAI）和淀粉样蛋白A（Serum amyloid A，SAA）表达水平变化，分析其与TBM病情和预后的关系。 方法 选择2017年3月-2021年1月本院收治的112例TBM患儿，根据英国医学研究理事会（Medical research council，MRC）分期标准分为Ⅰ期组（37例）、Ⅱ期组（46例）、Ⅲ期组（29例），根据改良Rankin量表（Modified Rankin Scale，mRS）评分将患儿分为预后良好组（0～2分，62例），预后不良组（≥3分，50例）。另选择71例健康儿童为对照组；检测血清CFH，ApoAI，SAA水平，分析其与TBM病情以及预后的关系。 结果 TBM 组血清CFH，SAA水平均高于对照组（P＜0.05），ApoAI水平低于对照组（P＜0.05）；重度组血清CFH，SAA水平高于中度组和轻度组（P＜0.05），ApoAI水平低于中度组和轻度组（P＜0.05）。MRC分期Ⅲ期、高水平CFH、高水平SAA是TBM患者预后不良的危险因素（P＜0.05），高水平ApoAI是TBM患者预后不良的保护因素（P＜0.05）。CFH，ApoAI，SAA水平预测TBM患者预后不良的曲线下面积为0.613、0.610、0.592，联合CFH，ApoAI，SAA水平曲线下面积为0.855，高于单独CFH，ApoAI，SAA（z=6.275、5.936、6.569，P＜0.05）。 结论 TBM患儿血清CFH，SAA水平升高，ApoAI水平降低，且与TBM患儿病情加重以及不良预后有关。
Abstract:
Objective To investigate the expression of complement factor H (CFH), apolipoprotein A1 (Apo AI), and amyloid A (SAA) in peripheral blood of children with tuberculous meningitis (TBM), and to analyze their relationship with the prognosis of TBM. Methods 112 children with TBM admitted to our hospital from March 2017 to January 2021 were divided into stage Ⅰ group (37 cases), Stage Ⅱ group (46 cases), and Stage Ⅲ group (29 cases) according to the British Medical Research Council (MRC) staging criteria. According to the modified Rankin scale (mRS) score, the children were divided into the good prognosis group (0-2 points,62 cases), and the poor prognosis group (≥3 points,50 cases).Another 71 healthy children were selected as the control group. Serum CFH, Apo AI and SAA levels were detected, and their relationship with disease severity and prognosis was analyzed. Results The serum CFH and SAA levels in the TBM group were higher than those in the control group (P < 0.05), while the serum Apo AI levels in the TBM group were lower than those in the control group (P< 0.05). The serum CFH and SAA levels in the severe group were higher than those in the moderate and mild groups (P < 0.05). The serum Apo AI levels were lower than those in moderate and mild groups (P< 0.05).MRC stage Ⅲ, high level of CFH, and SAA were risk factors for poor prognosis in TBM patients (P< 0.05). High level of Apo AI was a protective factor for poor prognosis in TBM patients (P< 0.05).CFH, Apo AI, SAA predicted poor prognosis of TBM patients with under the curve area of 0.613, 0.610, and 0.592, respectively. The area under the curve of combined CFH, Apo AI, and SAA is 0.855, higher than that of CFH, Apo AI, SAA alone (z =6.275, 5.936, 6.569, P< 0.05). Conclusion The serum CFH and SAA levels are increased, while the Apo AI levels are decreased in children with TBM, which was related to the aggravation of the disease and poor prognosis.

参考文献/References:

[1] Daniel BD, Grace GA, Natrajan M. Tuberculous meningitis in children: Clinical management & outcome[J]. Indian J Med Res, 2019, 150(2): 117-130.
[2] Mezochow A, Thakur K, Vinnard C. Tuberculous meningitis in children and adults: new insights for an ancient foe[J]. Curr Neurol Neurosci Rep, 2017, 17(11): 85.
[3] 郑笑,谢大星,郭广凤,等.补体因子H、补体因子H相关蛋白在IgA肾病诊断中的应用价值[J].山东医药,2018,58(46):16-19.
[4] 刘国平.结核病与血脂水平的相关性研究[J].黑龙江医学,2009,33(11):852-853.
[5] Li H, Xiang X, Ren HW, et al. Serum amyloid a is a biomarker of severe coronavirus disease and poor prognosis[J]. J Infect, 2020, 80(6): 646-655.
[6] 叶任高,陆再英.内科学[M].第6版.北京:人民卫生出版社,2004:156-160.
[7] 赵永波,刘功禄.结核性脑膜脑炎诊断与治疗[J].临床内科杂志,2009,26(12):804-807.
[8] Thwaites GE, Van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers[J]. Lancet Neurol, 2013, 12(10): 999-1010.
[9] Bamford JM, Sandercock PA, Warlow CP, et al. Interobserver agreement for the assessment of handicap in stroke patients[J]. Stroke, 1989, 20(6): 828.
[10]Wang MG, Luo L, Zhang Y, et al. Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis[J]. BMC Pulm Med, 2019, 19(1): 200.
[11]Rohlwink UK, Figaji A, Wilkinson KA, et al. Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity[J]. Nat Commun, 2019, 10(1): 3767.
[12]Wilkinson RJ, Rohlwink U, Misra UK, et al. Tuberculous meningitis[J]. Nat Rev Neurol, 2017, 13(10): 581-598.
[13]梁建琴,陈志. 糖皮质激素在结核病治疗中的合理应用专家共识[J]. 中国防痨杂志,2022,44(1):28-37.
[14]王强.2型糖尿病患者血清补体因子H与胰岛素抵抗相关性研究[J].临床和实验医学杂志,2017,16(5):460-463.
[15]王晓蓉,杨致蓉,王卫平,等.补体因子H基因Y402H位点多态性与精神分裂症及其临床特征的相关性分析[J].临床精神医学杂志,2017,27(3):145-148.
[16]Parente R, Clark SJ, Inforzato A, et al. Complement factor H in host defense and immune evasion[J]. Cell Mol Life Sci, 2017, 74(9): 1605-1624.
[17]Wu J, Wang Y, Li H, et al. Serum apolipoprotein B-to-apolipoprotein A1 ratio is independently associated with disease severity in patients with acute pancreatitis[J]. Sci Rep, 2019, 9(1): 7764.
[18]Poynard T, Deckmyn O, Rudler M, et al. Performance of serum apolipoprotein-A1 as a sentinel of Covid-19[J]. PLoS One, 2020, 15(11): e0242306.
[19]Orimadegun AE, Orimadegun BE. Serum Apolipoprotein-A1 and cholesterol levels in nigerian children with plasmodium falciparum infection[J]. Med Princ Pract, 2015, 24(4): 318-324.
[20]Georgila K, Vyrla D, Drakos E. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer[J]. Cancers (Basel), 2019, 11(8): 1097.
[21]Peng B, Qiu X, Dong Z, et al. Proteomic profiling of biomarkers by MALDI-TOF mass spectrometry for the diagnosis of tracheobronchial stenosis after tracheobronchial tuberculosis[J]. Exp Ther Med, 2021, 21(1): 63.
[22]杨丹丹.血清淀粉样蛋白A在系统性红斑狼疮中的表达及临床意义[J].标记免疫分析与临床,2020,27(3):428-431.
[23]Yoshimura S, Koziy RV, Dickinson R, et al. Use of serum amyloid A in serum and synovial fluid to detect eradication of infection in experimental septic arthritis in horses[J]. Can J Vet Res, 2020, 84(3): 198-204.
[24]Cheng L, Jz Y, Bai WH, et al. Prognostic value of serum amyloid A in patients with COVID-19[J]. Infection, 2020, 48(5): 715-722.
[25]Chen ES, Song Z, Willett MH, et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2[J]. Am J Respir Crit Care Med, 2010, 181(4): 360-373.
[26]Kawka M, Brzostek A, Dzitko K, et al. Mycobacterium tuberculosis Binds Human Serum Amyloid A, and the Interaction Modulates the Colonization of Human Macrophages and the Transcriptional Response of the Pathogen[J]. Cells, 2021, 10(5): 1264.

备注/Memo

备注/Memo:
基金项目：内蒙古自治区自然科学基金项目（2018MS113050）
更新日期/Last Update: 2022-10-10